Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial
Introduction Vasoplegia is a common complication after cardiac surgery and is associated with poor prognosis. It is characterised by refractory hypotension despite normal or even increased cardiac output. The pathophysiology is complex and includes the systemic inflammatory response caused by cardio...
Main Authors: | Can Ince, Jan H N Lindeman, Wilbert B van den Hout, Saskia L M A Beeres, Robert J M Klautz, Olga Papazisi, Eline F Bruggemans, Remco R Berendsen, Juan D V Hugo, M Sesmu Arbous, Bart J A Mertens, Meindert Palmen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/9/e061337.full |
Similar Items
-
Impact of CytoSorb® on interleukin-6 in cardiac surgery
by: Daniela Geisler, et al.
Published: (2023-08-01) -
Efficacy of CytoSorb®: a systematic review and meta-analysis
by: Sören Becker, et al.
Published: (2023-05-01) -
Hemoadsorption in the critically ill-Final results of the International CytoSorb Registry.
by: Fatime Hawchar, et al.
Published: (2022-01-01) -
Impact of CytoSorb and CKRT on hemodynamics in pediatric patients with septic shock: the PedCyto study
by: Gabriella Bottari, et al.
Published: (2023-09-01) -
Impact of CytoSorb Hemoadsorption Therapy on Fluid Balance in Patients with Septic Shock
by: Klaus Kogelmann, et al.
Published: (2024-01-01)